Pricing
  1. JP-listed companies
  3. Financials
  4. Revenue growth (%)

【JP:3417】

Market cap
¥19B
P/E ratio
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20254.4-55.44%
Mar 31, 20249.9+4.97%
Mar 31, 20239.5-437.50%
Mar 31, 2022-2.8-187.23%
Mar 31, 20213.2-55.85%
Mar 31, 20207.3-8.09%
Mar 31, 20197.9+2.33%
Mar 31, 20187.7+8.87%
Mar 31, 20177.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)